BioNTech partnering with La Trobe University
Вставка
- Опубліковано 28 вер 2024
- La Trobe University will be home to the manufacturing of new investigational mRNA therapies for serious diseases including cancer, with global biotechnology company BioNTech planning to develop and commission a state-of-the-art mRNA clinical-scale manufacturing facility at the University’s Melbourne campus in Bundoora, in an agreement facilitated by the Victorian Government.